However, Ben Hargreaves finds that the company’s role in the global HIV fight has been clouded by controversies over drug ...
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
GlobalData on MSN1d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Historically, as mentioned, PrEP has been used to treat cisgender gay men, especially in light of the HIV crisis of the 1980s ...
Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for ...
It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are ...
Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...
Oklahoma legalized needle exchange programs three years ago. Since then, over half a million clean syringes have been ...
Moderate and high SUD risk was significantly increased among people living with HIV during the COVID-19 pandemic, between 2018 and 2022.
Since that time, drugs have been developed for every step in the life cycle (Figure 1), forming the basis of modern treatment ...
IDWeek is the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback